Stem cell transplant and Paranasal sinus hypersecretion
Paranasal sinus hypersecretion is reported only by a few people with Stem cell transplant.
The study analyzes which people have Paranasal sinus hypersecretion with Stem cell transplant. It is created by eHealthMe based on 1 person who has Paranasal sinus hypersecretion and Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who has Stem Cell Transplant and Paranasal Sinus Hypersecretion is studied.
What is Stem cell transplant?
Stem cell transplant is found to be associated with 721 drugs and 337 conditions by eHealthMe.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 729 drugs and 394 conditions by eHealthMe.
Number of Paranasal sinus hypersecretion in Stem cell transplant reports submitted per year:
Gender of people who have Stem Cell Transplant and experienced Paranasal Sinus Hypersecretion *:
- female: 0.0 %
- male: 100 %
Age of people who have Stem Cell Transplant and experienced Paranasal Sinus Hypersecretion *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 100.00%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 100.00%
Common drugs taken by these people *:
- Triamcinolone: 1 person, 100.00%
- Reglan: 1 person, 100.00%
- Protonix: 1 person, 100.00%
- Prograf: 1 person, 100.00%
- Oxycodone: 1 person, 100.00%
- Melphalan: 1 person, 100.00%
- Marinol: 1 person, 100.00%
- Kytril: 1 person, 100.00%
- Ibrutinib: 1 person, 100.00%
- Claritin: 1 person, 100.00%
Common symptoms for these people *:
- Weight Fluctuation: 1 person, 100.00%
- Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 1 person, 100.00%
- Abdominal Mass (localized enlargement or swelling in the human abdomen): 1 person, 100.00%
- Abdominal Pain: 1 person, 100.00%
- Agitation (state of anxiety or nervous excitement): 1 person, 100.00%
- Allergic Rhinitis: 1 person, 100.00%
- Amylase Increased: 1 person, 100.00%
- Blood Alkaline Phosphatase Increased: 1 person, 100.00%
- Blood Creatinine Abnormal: 1 person, 100.00%
- Conjunctival Irritation: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (729 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (394 conditions)
How the study uses the data?
The study is based on Paranasal sinus hypersecretion and Stem cell transplant, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Enhertu and Ear Pain - 10 seconds ago
- Pantoprazole Sodium and Urinary Tract Infection - 13 seconds ago
- Valsartan and Quit Smoking - 26 seconds ago
- Gemzar and Gastrointestinal Infection - 40 seconds ago
- Atrovent Hfa and Osteoarthritis - 45 seconds ago
- Zyrtec and Pharyngitis Streptococcal - 47 seconds ago
- Colecalciferol and Metformin drug interaction - 54 seconds ago
- Spiriva and Oesophagitis Haemorrhagic - a minute ago
- Losartan and Vasculitic Rash - a minute ago
- Zyrtec and Activities Of Daily Living Impaired - a minute ago